Selective Inhibition by Antiflammin-2 of Thromboxane B Release from Isolated and Perfused Guinea-Pig Lung
Author Information
Author(s): Lidia Sautebin, Giuseppe Cirino, Massirno Di Rosa
Primary Institution: Department of Experimental Pharmacology, University of Naples Federico II
Hypothesis
Does antiflammin-2 (AF-2) selectively inhibit thromboxane B2 release in guinea-pig lungs depending on the stimulus applied?
Conclusion
Antiflammin-2 selectively inhibits thromboxane B2 release induced by certain stimuli in guinea-pig lungs but not others.
Supporting Evidence
- AF-2 inhibited leukotriene C4-induced TXB2 release in normal and sensitized lungs.
- AF-2 did not affect TXB2 release induced by histamine or bradykinin in normal lungs.
- AF-2 infusion reduced antigen-induced TXB2 release from sensitized lungs by 32%.
- AF-2 was ineffective in modifying TXB2 and histamine release from chopped lung fragments.
Takeaway
This study found that a peptide called antiflammin-2 can stop certain chemicals from being released in guinea pig lungs, but it doesn't work for everything.
Methodology
The study used isolated and perfused guinea-pig lungs to measure the release of thromboxane B2 and histamine in response to various stimuli with and without antiflammin-2.
Limitations
The study's findings may not be applicable to other species or different experimental conditions.
Participant Demographics
Male guinea-pigs (Dunkin Hartley, 300-400g)
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website